Javascript Menu by Deluxe-Menu.com
 
  Providing Next Generation Vaccines
Improving Human Health

Corporate

Home Page Send Email
 

Management


Read their biographical sketches

ITI's Management Team is composed of experienced and respected biotechnology professionals. New to the Immunomics Team are the following professionals:

  • Bernard C. Rudnick as CFO

  • Winston Lowe as Secretary and Corporate Counsel

  • Ronald Thiboutot as a Member of the Board of Directors

  • Kal Vepuri as an Member of the Board of Directors (observer)

  • Lisa Salley as COO

  • Colin Magowan as Business Development Director

  • Robert Rager as head of Grant Development

  • Tama Copeman as advisor and chair of the IP Management Committee


Bill Hearl, Ph.D.
President & CEO
 
 

J. Thomas August, M.D.
Scientific Founder
 
 

Teri Jones-Heiland, Ph.D.
Vice President, R&D
 
 

W. Barry McDonald
Board Member, Business Development
 
 

Bruce F. Mackler, Ph.D., J.D.
Board Member, RA & Development
 
 

James W. Wishart
Board Member, Finance
 
 

Our Board of Directors & Advisory Boards are composed of established and proven industry executives and world renown scientific leaders.

Our Team supports ITI's management's efforts in business development, scientific analysis, collaborations and innovative thinking. With collectively well over 100 years of industry relevant experience, ITI's Management & Board are creating a world-class biotechnology company. It's in our DNA!

• Board of Directors

• Business Advisors

• Scientific Advisors

 
 
 

News | About Us | Links | Contact Information | Directions    Immunomic Therapeutics, Inc.
313 W. Liberty St., Suite 343
Lancaster, PA 17603
Phone: 1-717-327-1919
© 2008-2010 Immunomic Therapeutics, Inc. All rights reserved